SR
Sutapa Ray
University of Nebraska Medical Center, University of Texas Medical Branch at Galveston, Indian Institute of Chemical Biology CSIR, University of Texas Southwestern Department of Pharmacology
0000-0003-4234-2124
Employment
-
University of Nebraska Medical Center2015 - Present
-
University of Texas Medical Branch at Galveston1999 - 2013
-
University of Texas Southwestern Department of Pharmacology1997 - 1999
Education
-
Indian Institute of Chemical Biology CSIR PhD
Projects & Funding
Projects & funding information is unavailable.
Publications (33)
- Independent validation of the PrecivityAD2™ blood test to identify presence or absence of brain amyloid pathology in individuals with cognitive impairment Save
- STAT3 Inhibition Attenuates MYC Expression by Modulating Co-Activator Recruitment and Suppresses Medulloblastoma Tumor Growth by Augmenting Cisplatin Efficacy In Vivo Save
- The human AP-endonuclease 1 (APE1) is a DNA G-quadruplex structure binding protein and regulates KRAS expression in pancreatic ductal adenocarcinoma cells. Save
- Subgroup-Specific Diagnostic, Prognostic, and Predictive Markers Influencing Pediatric Medulloblastoma Treatment. Save
- The FAcilitates Chromatin Transcription (FACT) complex: Its roles in DNA repair and implications for cancer therapy. Save
- Synergistic efficacy of inhibiting MYCN and mTOR signaling against neuroblastoma. Save
- Histone chaperone FACT complex inhibitor CBL0137 interferes with DNA damage repair and enhances sensitivity of medulloblastoma to chemotherapy and radiation. Save
- A novel combination approach targeting an enhanced protein synthesis pathway in MYC-driven (Group 3) medulloblastoma Save
- Targeting histone chaperone FACT complex overcomes 5-fluorouracil resistance in colon cancer Save
- Role of protein arginine methyltransferase 5 in group 3 (MYC-driven) Medulloblastoma Save